SNNA

Sienna Biopharmaceuticals, Inc.
SNNA

Overview Fund Activity
Delisted

SNNA was delisted on the 16th of December, 2019.

Back to rankings

34 hedge funds and large institutions have $178M invested in Sienna Biopharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$66.2M
2
PHS
PFM Health Sciences
California
+$35.2M
3
OFM
Omega Fund Management
Massachusetts
+$16.9M
4
CCP
Clough Capital Partners
Massachusetts
+$16.4M
5
Victory Capital Management
Victory Capital Management
Texas
+$10.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
AIG
26
American International Group
New York
$73K +$73K +3,265 New
UBS Group
27
UBS Group
Switzerland
$55K +$55K +2,488 New
NFA
28
Nationwide Fund Advisors
Ohio
$43K +$43K +1,936 New
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$38K +$38K +1,700 New
SO
30
STRS Ohio
Ohio
$33K +$33K +1,500 New
Legal & General Group
31
Legal & General Group
United Kingdom
$14K +$14K +651 New
Wells Fargo
32
Wells Fargo
California
$8K +$8K +351 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$8K +$8K +354 New
Bank of America
34
Bank of America
North Carolina
$5K +$5K +236 New
1
2